Skip to main content

Table 1 Model inputs

From: Which assisted reproductive technology (ART) treatment strategy is the most clinically and cost-effective for women of advanced maternal age: a Markov model

 

Probability estimates

Distribution

References

Per Cycle

Initiated cycles reaching oocyte pick-up (OPU)

 Age 35–39

0.93

Beta

[18]

 Age 40–44

0.90

Beta

[18]

 Age 45

0.85

Beta

[18]

Progression to fresh cycle

 Age 35–39

0.765

Beta

[18]

 Age 40–44

0.707

Beta

[18]

 Age 45

0.707

Beta

[18]

Autologous ART

 Cumulative live birth rate per OPU

 Age 35

0.325

Beta

[18]

  36

0.286

Beta

[18]

  37

0.249

Beta

[18]

  38

0.213

Beta

[18]

  39

0.179

Beta

[18]

  40

0.160

Beta

[18]

  41

0.142

Beta

[18]

  42

0.107

Beta

[18]

  43

0.074

Beta

[18]

  44

0.043

Beta

[18]

  45

0.014

Beta

[18]

Social Freezing

 Cumulative live birth rate

 Age 40

0.351

Beta

[18, 15]

  41

0.338

Beta

[18, 15]

  42

0.325

Beta

[18, 15]

  43

0.313

Beta

[18, 15]

  44

0.300

Beta

[18, 15]

  45

0.287

Beta

[18, 15]

PGT-A

 Cumulative live birth rate

 Age 35

0.337

Beta

[211]

  36

0.295

Beta

[211]

  37

0.244

Beta

[211]

  38

0.194

Beta

[211]

  39

0.166

Beta

[211]

  40

0.153

Beta

[2]

  41

0.149

Beta

[2]

  42

0.147

Beta

[2]

  43

0.140

Beta

[2]

  44

0.120

Beta

[2]

  45

0.082

Beta

[2]

Donor ART

 Cumulative live birth rate

 Age 35

0.380

Beta

[18]

  36

0.380

Beta

[18]

  37

0.380

Beta

[18]

  38

0.317

Beta

[18]

  39

0.317

Beta

[18]

  40

0.317

Beta

[19]

  41

0.329

Beta

[19]

  42

0.329

Beta

[19]

  43

0.378

Beta

[19]

  44

0.378

Beta

[19]

  45

0.333

Beta

[19]